• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型 N,O- 或 N,N- 供体铜(II)配合物的合成与结构作为自由基清除剂及金属酶活性中心的功能模型。

Synthesis and Structure of Novel Copper(II) Complexes with N,O- or N,N-Donors as Radical Scavengers and a Functional Model of the Active Sites in Metalloenzymes.

机构信息

Institute of Chemistry, Jan Kochanowski University in Kielce, Uniwersytecka 7, 25-406 Kielce, Poland.

Institute of Physical Chemistry, Polish Academy of Sciences, Kasprzaka 44/52, 01-224 Warsaw, Poland.

出版信息

Int J Mol Sci. 2021 Jul 6;22(14):7286. doi: 10.3390/ijms22147286.

DOI:10.3390/ijms22147286
PMID:34298905
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8307904/
Abstract

To evaluate the antioxidant activity of potential synthetic enzyme mimetics, we prepared new five copper(II) complexes via a self-assembly method and named them Cu(2-(HOCH)py) (), [Cu(2-(HOCH)py)(HO)]SiF (), Cu(2-(HOCHCH)py)(2-(OCHCH)py) (), Cu(pyBIm)·1.5HO () and Cu(pyC(OH)) (). The synthetic protocol involved N,O- or N,N-donors: 2-(hydroxymethyl)pyridine (2-(HOCH)py), 2-(hydroxyethyl)pyridine (2-(HOCHCH)py), 2-(2-pyridyl)benzimidazole (pyBIm), di(2-pyridyl)ketone (pyCO). The obtained Cu(II) complexes were fully characterised by elemental analysis, FTIR, EPR, UV-Vis, single-crystal X-ray diffraction and Hirshfeld surface analysis. Crystallographic and spectroscopic analyses confirmed chromophores of both monomeric ({CuNO} (), {CuNO} (), {CuN} (), {CuNO} ()) and dimeric complex ({CuNO} ()). Most of the obtained species possessed a distorted octahedral environment, except dimer , which consisted of two copper centres with square pyramidal geometries. The water-soluble compounds (, and ) were selected for biological testing. The results of the study revealed that complex in solutions displayed better radical scavenging activity than complexes , and free ligands. Therefore, complex has been selected for further studies to test its activity as an enzyme mimetic. The chosen compound was tested on the erythrocyte lysate of two groups of patients after undergoing chemotherapy and chemoradiotherapy. The effect of the tested compound () on enzyme activity levels (TAS, SOD and CAT) suggests that the selected complex can be treated as a functional mimetic of the enzymes.

摘要

为了评估潜在合成酶模拟物的抗氧化活性,我们通过自组装方法制备了五个新的五铜(II)配合物,并将其命名为 Cu(2-(HOCH)py) ()、[Cu(2-(HOCH)py)(HO)]SiF ()、Cu(2-(HOCHCH)py)(2-(OCHCH)py) ()、Cu(pyBIm)·1.5HO () 和 Cu(pyC(OH)) ()。合成方案涉及 N,O- 或 N,N-供体:2-(羟甲基)吡啶 (2-(HOCH)py)、2-(羟乙基)吡啶 (2-(HOCHCH)py)、2-(2-吡啶基)苯并咪唑 (pyBIm)、二(2-吡啶基)酮 (pyCO)。通过元素分析、FTIR、EPR、UV-Vis、单晶 X 射线衍射和 Hirshfeld 表面分析对获得的 Cu(II)配合物进行了全面表征。晶体学和光谱分析证实了单体({CuNO} ()、{CuNO} ()、{CuN} ()、{CuNO} ())和二聚体配合物 ({CuNO} () )的发色团。获得的大多数物种具有扭曲的八面体环境,除了二聚体 ,它由两个具有正方形锥几何形状的铜中心组成。选择水溶性化合物(、和)进行生物测试。研究结果表明,配合物 在溶液中显示出比配合物 、和游离配体更好的自由基清除活性。因此,选择配合物 进行进一步研究,以测试其作为酶模拟物的活性。选择的化合物在接受化疗和放化疗的两组患者的红细胞裂解物上进行了测试。测试化合物 ()对酶活性水平(TAS、SOD 和 CAT)的影响表明,所选配合物可以作为酶的功能模拟物进行治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0804/8307904/4014e078bf57/ijms-22-07286-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0804/8307904/de8ade29314f/ijms-22-07286-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0804/8307904/8472d01b2ebf/ijms-22-07286-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0804/8307904/1a30523e35d5/ijms-22-07286-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0804/8307904/6c593a28a558/ijms-22-07286-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0804/8307904/23940687594b/ijms-22-07286-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0804/8307904/5c06c93c2d62/ijms-22-07286-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0804/8307904/4370388cd4e9/ijms-22-07286-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0804/8307904/dd20a7064b07/ijms-22-07286-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0804/8307904/43263a25fd03/ijms-22-07286-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0804/8307904/25e82c37c914/ijms-22-07286-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0804/8307904/01030391d34c/ijms-22-07286-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0804/8307904/c3b1e6c3cf2c/ijms-22-07286-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0804/8307904/0421fc41a93a/ijms-22-07286-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0804/8307904/0827398f0e3a/ijms-22-07286-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0804/8307904/62027d022a7d/ijms-22-07286-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0804/8307904/4014e078bf57/ijms-22-07286-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0804/8307904/de8ade29314f/ijms-22-07286-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0804/8307904/8472d01b2ebf/ijms-22-07286-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0804/8307904/1a30523e35d5/ijms-22-07286-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0804/8307904/6c593a28a558/ijms-22-07286-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0804/8307904/23940687594b/ijms-22-07286-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0804/8307904/5c06c93c2d62/ijms-22-07286-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0804/8307904/4370388cd4e9/ijms-22-07286-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0804/8307904/dd20a7064b07/ijms-22-07286-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0804/8307904/43263a25fd03/ijms-22-07286-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0804/8307904/25e82c37c914/ijms-22-07286-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0804/8307904/01030391d34c/ijms-22-07286-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0804/8307904/c3b1e6c3cf2c/ijms-22-07286-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0804/8307904/0421fc41a93a/ijms-22-07286-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0804/8307904/0827398f0e3a/ijms-22-07286-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0804/8307904/62027d022a7d/ijms-22-07286-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0804/8307904/4014e078bf57/ijms-22-07286-g014.jpg

相似文献

1
Synthesis and Structure of Novel Copper(II) Complexes with N,O- or N,N-Donors as Radical Scavengers and a Functional Model of the Active Sites in Metalloenzymes.新型 N,O- 或 N,N- 供体铜(II)配合物的合成与结构作为自由基清除剂及金属酶活性中心的功能模型。
Int J Mol Sci. 2021 Jul 6;22(14):7286. doi: 10.3390/ijms22147286.
2
Copper(II) complexes of pyridyl-appended diazacycloalkanes: synthesis, characterization, and application to catalytic olefin aziridination.吡啶基取代的二氮杂环烷烃的铜(II)配合物:合成、表征及其在催化烯烃氮杂环丙烷化反应中的应用
Inorg Chem. 2000 Oct 16;39(21):4913-20. doi: 10.1021/ic000664+.
3
Copper(II) complexes with the non-steroidal anti-inflammatory drug tolfenamic acid: Structure and biological features.铜(II)与非甾体抗炎药托芬那酸的配合物:结构与生物学特性
J Inorg Biochem. 2015 Aug;149:68-79. doi: 10.1016/j.jinorgbio.2015.02.019. Epub 2015 Mar 6.
4
The chemical biology of Cu(II) complexes with imidazole or thiazole containing ligands: Synthesis, crystal structures and comparative biological activity.含咪唑或噻唑配体的铜(II)配合物的化学生物学:合成、晶体结构及比较生物学活性
J Inorg Biochem. 2016 Apr;157:52-61. doi: 10.1016/j.jinorgbio.2016.01.014. Epub 2016 Jan 11.
5
Trigonal planar copper(I) complex: synthesis, structure, and spectra of a redox pair of novel copper(II/I) complexes of tridentate bis(benzimidazol-2'-yl) ligand framework as models for electron-transfer copper proteins.三角平面铜(I)配合物:具有三齿双(苯并咪唑-2'-基)配体骨架的新型铜(II/I)配合物氧化还原对的合成、结构及光谱,作为电子转移铜蛋白的模型
Inorg Chem. 2001 May 7;40(10):2246-55. doi: 10.1021/ic0003372.
6
Copper(I) complexes, copper(I)/O(2) reactivity, and copper(II) complex adducts, with a series of tetradentate tripyridylalkylamine tripodal ligands.具有一系列四齿三吡啶基烷基胺三脚架配体的铜(I)配合物、铜(I)/氧气反应性以及铜(II)配合物加合物。
Inorg Chem. 2001 May 7;40(10):2312-22. doi: 10.1021/ic000924n.
7
Coordination diversity in mono- and oligonuclear copper(II) complexes of pyridine-2-hydroxamic and pyridine-2,6-dihydroxamic acids.吡啶-2-羟肟酸和吡啶-2,6-二羟肟酸单核和寡核铜(II)配合物的配位多样性。
Inorg Chem. 2013 Jul 1;52(13):7633-44. doi: 10.1021/ic4007229. Epub 2013 Jun 18.
8
Five-Coordinated Geometries from Molecular Structures to Solutions in Copper(II) Complexes Generated from Polydentate--Donor Ligands and Pseudohalides.五配位几何结构:从分子结构到铜(II)配合物溶液中的配位环境
Molecules. 2020 Jul 25;25(15):3376. doi: 10.3390/molecules25153376.
9
Synthesis, X-ray crystal structures and biomimetic and anticancer activities of novel copper(II)benzoate complexes incorporating 2-(4'-thiazolyl)benzimidazole (thiabendazole), 2-(2-pyridyl)benzimidazole and 1,10-phenanthroline as chelating nitrogen donor ligands.新型苯甲酸铜(II)配合物的合成、X射线晶体结构以及仿生和抗癌活性,该配合物包含2-(4'-噻唑基)苯并咪唑(噻苯达唑)、2-(2-吡啶基)苯并咪唑和1,10-菲咯啉作为螯合氮供体配体。
J Inorg Biochem. 2007 Jun;101(6):881-92. doi: 10.1016/j.jinorgbio.2007.02.002. Epub 2007 Feb 14.
10
Synthesis, molecular structure and antioxidant activity of bis [L(μ-chloro)copper(II)] supported by phenoxy/naphthoxy-imine ligands.双[L(μ-氯)铜(II)]配合物的合成、分子结构与抗氧化活性。配体为苯氧基/萘氧基-亚胺。
J Inorg Biochem. 2020 Sep;210:111130. doi: 10.1016/j.jinorgbio.2020.111130. Epub 2020 Jun 11.

引用本文的文献

1
Copper(ii) complexes with 2-ethylpyridine and related hydroxyl pyridine derivatives: structural, spectroscopic, magnetic and anticancer studies.铜(II)与2-乙基吡啶及相关羟基吡啶衍生物的配合物:结构、光谱、磁性及抗癌研究
RSC Adv. 2022 Sep 28;12(42):27648-27665. doi: 10.1039/d2ra05133h. eCollection 2022 Sep 22.
2
Ultrasonic Clusterization Process to Prepare [(NNCO)CoCl] as a Novel Double-Open-CoO Cubane Cluster: SXRD Interactions, DFT, Physicochemical, Thermal Behaviors, and Biomimicking of Catecholase Activity.用于制备[(NNCO)CoCl]作为新型双开口CoO立方烷簇的超声聚集过程:同步辐射X射线衍射相互作用、密度泛函理论、物理化学性质、热行为以及儿茶酚酶活性的仿生研究
ACS Omega. 2022 Sep 7;7(37):32949-32958. doi: 10.1021/acsomega.1c07032. eCollection 2022 Sep 20.

本文引用的文献

1
Structural Insights into New Bi(III) Coordination Polymers with Pyridine-2,3-Dicarboxylic Acid: Photoluminescence Properties and Anti- Activity.新型 Bi(III) 配合物与吡啶-2,3-二羧酸的结构研究:荧光性质和抗活性。
Int J Mol Sci. 2020 Nov 18;21(22):8696. doi: 10.3390/ijms21228696.
2
Ruthenium(II) and Iridium(III) Complexes as Tested Materials for New Anticancer Agents.钌(II)和铱(III)配合物作为新型抗癌药物的测试材料
Materials (Basel). 2020 Aug 7;13(16):3491. doi: 10.3390/ma13163491.
3
Similarities and differences in d low-spin ruthenium, rhodium and iridium half-sandwich complexes: synthesis, structure, cytotoxicity and interaction with biological targets.
低自旋钌、铑和铱半夹心配合物的相似性和差异性:合成、结构、细胞毒性及与生物靶标的相互作用。
J Biol Inorg Chem. 2019 Jun;24(4):591-606. doi: 10.1007/s00775-019-01665-2. Epub 2019 May 21.
4
Chemical Basis of Reactive Oxygen Species Reactivity and Involvement in Neurodegenerative Diseases.活性氧物种反应性的化学基础及其在神经退行性疾病中的作用。
Int J Mol Sci. 2019 May 15;20(10):2407. doi: 10.3390/ijms20102407.
5
Oxidative stress response induced by chemotherapy in leukemia treatment.化疗在白血病治疗中引发的氧化应激反应。
Mol Clin Oncol. 2018 Mar;8(3):391-399. doi: 10.3892/mco.2018.1549. Epub 2018 Jan 10.
6
Processing of X-ray diffraction data collected in oscillation mode.振荡模式下收集的X射线衍射数据的处理。
Methods Enzymol. 1997;276:307-26. doi: 10.1016/S0076-6879(97)76066-X.
7
Assembled structures of tetrakis(biimidazole)dirhodium complexes hydrogen-bonded with common inorganic anions.与常见无机阴离子形成氢键的四(联咪唑)二铑配合物的组装结构。
Acta Crystallogr B Struct Sci Cryst Eng Mater. 2014 Dec;70(Pt 6):1006-19. doi: 10.1107/S2052520614021428. Epub 2014 Dec 1.
8
Effective catalytic disproportionation of aqueous H2O2 with di- and mono-nuclear manganese(II) complexes containing pyridine alcohol ligands.含吡啶醇配体的双核和单核锰(II)配合物对过氧化氢水溶液的有效催化歧化反应
Dalton Trans. 2014 Jun 21;43(23):8599-608. doi: 10.1039/c3dt53288g.
9
A novel single-site manganese(II) complex of a pyridine derivative as a catalase mimetic for disproportionation of H2O2 in water.一种新型吡啶衍生物的单原子锰(II)配合物作为过氧化氢歧化反应的模拟酶,用于水中 H2O2 的分解。
Dalton Trans. 2013 Jun 7;42(21):7761-7. doi: 10.1039/c3dt50288k.
10
Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling.细胞信号转导中的活性氧(ROS)稳态和氧化还原调节。
Cell Signal. 2012 May;24(5):981-90. doi: 10.1016/j.cellsig.2012.01.008. Epub 2012 Jan 20.